SWISSAVANS SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron
The spread of the new variant “Omicron” is faster than expected. The countries and regions with reported Omicron cases on the GISAID website have been increased to twenty-one on Dec. 2, 2021. The data only showed the number of submitted sequenced cases, which might be just the tip of the iceberg.
Scientists in South Africa on November 24, 2021, identified a concerning new variant of the coronavirus, whose mutations mark a "big jump in evolution" that is driving a spike in new cases. Hours later, Britain banned flights from six southern African nations, citing the variant. Later this variant was also detected in Botswana, Hong Kong, Italy, Israel, Australia, Germany, France, Switzerland, UK, Netherlands, Canada, Demark, Austria, Czech Republic, and Belgium…
The variant Omicron, also known as B.1.1.529, is primarily of concern due to the large number of mutations it has in the Spike gene. Many of these variants are in the binding receptor-binding domain and N-terminal domain, and thus may play key roles in ACE2 binding and antibody recognition, which might help it evade vaccines and make it more contagious.
IMPORTANT LINK FOR COVID -19
 Clinical Management of Severe Acute Respiratory Infection When Novel
Coronavirus (2019 nCoV) Infection is Suspected. WHO. 2020.
 Interim Measures for the Management of Clinical DNA Amplification Testing Laboratories YWF  No.10.
 Omicron (B.1.1.529): Infectivity, vaccine break through, and antibody resistance
Basel Office (HQ)
Basel Grosspeter Tower
CH-4052 Basel, Switzerland
T +41 (0) 61 564 12 34
Christoph Merian-Ring 11
CH-4153 Reinach, Switzerland
T +41 (0) 61 271 70 70
F +41 (0) 61 271 70 71
Copyright 2012 © Swissavans AG. All rights reserved.